Not necessarily, even if another company beats them to market and has a better vaccine - they will still get $2bln, it's easier to work when you are not under t

Not necessarily, even if another company beats them to market and has a better vaccine - they will still get $2bln, it's easier to work when you are not under time pressure to beat the market.